The expanding demand for specific immunological investigation and therapeutic design has spurred significant advances in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently produced using various expression platforms, including prokaryotic hosts, higher cell populations, and baculo